TP53 and central nervous system cancer: In addition, most of glioma cells with wild-type p53 exhibit a high resistance to cytotoxic treatments used in clinical practice compared with glioma cells with transcriptionally inactive mutant p53.32 It appears that p53 activities associated with DNA repair contribute to the overall survival potential and drug resistance.